Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Han BiomedicalROCO:6999 26 Forward Dividend Yield % is 1.72% as of Jul. 20, 2026. GuruFocus rates ROCO:6999 with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 149 Biotechnology companies, Han Biomedical ranks better than 58.39% on this metric.
As of today (2026-07-20), the Forward Annual Dividend Yield of Han Biomedical is 1.72%.
As of today (2026-07-20), the Trailing Annual Dividend Yield of Han Biomedical is 2.06%.
ROCO:6999's Forward Dividend Yield % is ranked better than 58.39% of 149
companies
in the Biotechnology industry
Industry Median: 1.32
vs ROCO:6999: 1.72
During the past 12 months, Han Biomedical's average Dividends Per Share Growth Rate was 46.30% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Han Biomedical (ROCO:6999) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Han Biomedical Forward Dividend Yield % Related Terms
ROCO:6999 vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison
For the Biotechnology subindustry, Han Biomedical's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Han Biomedical Forward Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Han Biomedical's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Han Biomedical's Forward Dividend Yield % falls into.
Han Biomedical Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Han Biomedical Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 0.600000
2025-08-07
2025-08-08
2025-09-12
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Han Biomedical's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.6
/
29.10
=
2.06 %
Current Share Price is NT$29.10. Han Biomedical's Dividends per Share for the forward twelve months is calculated as NT$0.6 * 1 = NT$0.6.
Han Biomedical's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.6
/
29.10
=
2.06 %
Current Share Price is NT$29.10. Han Biomedical's Dividends per Share for the trailing twelve months (TTM) ended in Today is NT$0.6.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 1.72% mean?
Han Biomedical (ROCO:6999) has a Forward Dividend Yield % of 1.72% as of Jul. 20, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Han Biomedical and its competitors. According to the industry distribution chart, Han Biomedical ranks #62 out of 149 companies in the Biotechnology industry, placing it in the top 41.6%.
Is Han Biomedical's Forward Dividend Yield % too high?
Han Biomedical's current Forward Dividend Yield % is 1.72%. The Biotechnology industry median Forward Dividend Yield % is 1.32. Han Biomedical's value of 1.72% is 30.3% above this industry median. Based on the distribution chart, Han Biomedical ranks #62 out of 149 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Han Biomedical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Han Biomedical ranks #62 out of 149 companies for Forward Dividend Yield %. This puts Han Biomedical in the upper half of its industry. The industry median Forward Dividend Yield % is 1.32. Han Biomedical's value of 1.72% is 30.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.32, based on 149 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Han Biomedical's current Forward Dividend Yield % of 1.72% is 30.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Han Biomedical and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Han Biomedical's current Forward Dividend Yield % is 1.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current Forward Dividend Yield % of 1.72%. The current Forward Dividend Yield % is 1.72% and 30.3% above the Biotechnology industry median of 1.32. Han Biomedical's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current Forward Dividend Yield % is 1.72% as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6999 has been successfully added to your 
